Explore
Validate
Learn16731-1-AP
antibody from Proteintech Group
Targeting: EXOSC10
p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16731-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16731-1-AP, RRID:AB_2101730
- Product name
- EXOSC10 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated EXOSC10 antibody (Cat. #16731-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification.
Meng ZY, Fan YC, Zhang CS, Zhang LL, Wu T, Nong MY, Wang T, Chen C, Jiang LH
PeerJ 2023;11:e15860
PeerJ 2023;11:e15860
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 16731-1-AP(EXOSC10 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human spleen using 16731-1-AP(EXOSC10 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The EXOSC10 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human EXOSC10. This antibody recognizes human, mouse, rat antigen. The EXOSC10 antibody has been validated for the following applications: ELISA, WB, IHC analysis.
